Biologics for the prevention of infectious gastroenteritis in pigs and epidemic diarrhea in pigs
The global market for Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine players cover CNADC, Harbin Pharm, DBN, Ringpu and Wuhan Zhongbo Biology, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine market, with both quantitative and qualitative data, to help readers understand how the Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Box.
Market Segmentation:
The study segments the Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine market and forecasts the market size by Activity (Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine, Live and Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine, Inactivated,), by Downstream (Farms and Individual.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by activity
Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine, Live
Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine, Inactivated
Segmentation by downstream
Farms
Individual
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
CNADC
Harbin Pharm
DBN
Ringpu
Wuhan Zhongbo Biology
Nannong Hi-tech
HPBG
Huizhong Biolgoical
Qilu Animal Health
Haid Group
Zhenye Biologcal
Tecbond
Jilin Teyan Biolgoical
Nisseiken
KM Biologics
Chapter Introduction
Chapter 1: Scope of Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine, Research Methodology, etc.
Chapter 2: Executive Summary, global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine market size (sales and revenue) and CAGR, Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine market size by region, by activity, by downstream, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by activity, and activity.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine market size forecast by region, by country, by activity, and downstream.
Chapter 13: Comprehensive company profiles of the leading players, including CNADC, Harbin Pharm, DBN, Ringpu, Wuhan Zhongbo Biology, Nannong Hi-tech, HPBG, Huizhong Biolgoical and Qilu Animal Health, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Segment by Activity
2.2.1 Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine, Live
2.2.2 Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine, Inactivated
2.3 Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Activity
2.3.1 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share by Activity (2017-2022)
2.3.2 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue and Market Share by Activity (2017-2022)
2.3.3 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sale Price by Activity (2017-2022)
2.4 Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Segment by Downstream
2.4.1 Farms
2.4.2 Individual
2.5 Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Downstream
2.5.1 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sale Market Share by Downstream (2017-2022)
2.5.2 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue and Market Share by Downstream (2017-2022)
2.5.3 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sale Price by Downstream (2017-2022)
3 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine by Company
3.1 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Breakdown Data by Company
3.1.1 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue by Company (2020-2022)
3.2.2 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sale Price by Company
3.4 Key Manufacturers Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Location Distribution
3.4.2 Players Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine by Geographic Region
4.1 World Historic Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Annual Revenue by Geographic Region
4.2 World Historic Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Annual Revenue by Country/Region
4.3 Americas Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Growth
4.4 APAC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Growth
4.5 Europe Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Growth
4.6 Middle East & Africa Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Growth
5 Americas
5.1 Americas Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Country
5.1.1 Americas Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Country (2017-2022)
5.1.2 Americas Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue by Country (2017-2022)
5.2 Americas Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Activity
5.3 Americas Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Downstream
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Region
6.1.1 APAC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Region (2017-2022)
6.1.2 APAC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue by Region (2017-2022)
6.2 APAC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Activity
6.3 APAC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Downstream
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine by Country
7.1.1 Europe Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Country (2017-2022)
7.1.2 Europe Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue by Country (2017-2022)
7.2 Europe Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Activity
7.3 Europe Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Downstream
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine by Country
8.1.1 Middle East & Africa Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Activity
8.3 Middle East & Africa Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Downstream
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine
10.3 Manufacturing Process Analysis of Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine
10.4 Industry Chain Structure of Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Distributors
11.3 Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Customer
12 World Forecast Review for Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine by Geographic Region
12.1 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Market Size Forecast by Region
12.1.1 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Forecast by Region (2023-2028)
12.1.2 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Forecast by Activity
12.7 Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Forecast by Downstream
13 Key Players Analysis
13.1 CNADC
13.1.1 CNADC Company Information
13.1.2 CNADC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
13.1.3 CNADC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 CNADC Main Business Overview
13.1.5 CNADC Latest Developments
13.2 Harbin Pharm
13.2.1 Harbin Pharm Company Information
13.2.2 Harbin Pharm Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
13.2.3 Harbin Pharm Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Harbin Pharm Main Business Overview
13.2.5 Harbin Pharm Latest Developments
13.3 DBN
13.3.1 DBN Company Information
13.3.2 DBN Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
13.3.3 DBN Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 DBN Main Business Overview
13.3.5 DBN Latest Developments
13.4 Ringpu
13.4.1 Ringpu Company Information
13.4.2 Ringpu Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
13.4.3 Ringpu Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Ringpu Main Business Overview
13.4.5 Ringpu Latest Developments
13.5 Wuhan Zhongbo Biology
13.5.1 Wuhan Zhongbo Biology Company Information
13.5.2 Wuhan Zhongbo Biology Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
13.5.3 Wuhan Zhongbo Biology Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Wuhan Zhongbo Biology Main Business Overview
13.5.5 Wuhan Zhongbo Biology Latest Developments
13.6 Nannong Hi-tech
13.6.1 Nannong Hi-tech Company Information
13.6.2 Nannong Hi-tech Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
13.6.3 Nannong Hi-tech Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Nannong Hi-tech Main Business Overview
13.6.5 Nannong Hi-tech Latest Developments
13.7 HPBG
13.7.1 HPBG Company Information
13.7.2 HPBG Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
13.7.3 HPBG Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 HPBG Main Business Overview
13.7.5 HPBG Latest Developments
13.8 Huizhong Biolgoical
13.8.1 Huizhong Biolgoical Company Information
13.8.2 Huizhong Biolgoical Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
13.8.3 Huizhong Biolgoical Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Huizhong Biolgoical Main Business Overview
13.8.5 Huizhong Biolgoical Latest Developments
13.9 Qilu Animal Health
13.9.1 Qilu Animal Health Company Information
13.9.2 Qilu Animal Health Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
13.9.3 Qilu Animal Health Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Qilu Animal Health Main Business Overview
13.9.5 Qilu Animal Health Latest Developments
13.10 Haid Group
13.10.1 Haid Group Company Information
13.10.2 Haid Group Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
13.10.3 Haid Group Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Haid Group Main Business Overview
13.10.5 Haid Group Latest Developments
13.11 Zhenye Biologcal
13.11.1 Zhenye Biologcal Company Information
13.11.2 Zhenye Biologcal Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
13.11.3 Zhenye Biologcal Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Zhenye Biologcal Main Business Overview
13.11.5 Zhenye Biologcal Latest Developments
13.12 Tecbond
13.12.1 Tecbond Company Information
13.12.2 Tecbond Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
13.12.3 Tecbond Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Tecbond Main Business Overview
13.12.5 Tecbond Latest Developments
13.13 Jilin Teyan Biolgoical
13.13.1 Jilin Teyan Biolgoical Company Information
13.13.2 Jilin Teyan Biolgoical Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
13.13.3 Jilin Teyan Biolgoical Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Jilin Teyan Biolgoical Main Business Overview
13.13.5 Jilin Teyan Biolgoical Latest Developments
13.14 Nisseiken
13.14.1 Nisseiken Company Information
13.14.2 Nisseiken Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
13.14.3 Nisseiken Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Nisseiken Main Business Overview
13.14.5 Nisseiken Latest Developments
13.15 KM Biologics
13.15.1 KM Biologics Company Information
13.15.2 KM Biologics Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
13.15.3 KM Biologics Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 KM Biologics Main Business Overview
13.15.5 KM Biologics Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine, Live
Table 4. Major Players of Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine, Inactivated
Table 5. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Activity (2017-2022) & (Box)
Table 6. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share by Activity (2017-2022)
Table 7. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue by Activity (2017-2022) & ($ million)
Table 8. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Market Share by Activity (2017-2022)
Table 9. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sale Price by Activity (2017-2022) & (US$/Box)
Table 10. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Downstream (2017-2022) & (Box)
Table 11. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share by Downstream (2017-2022)
Table 12. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue by Downstream (2017-2022)
Table 13. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Market Share by Downstream (2017-2022)
Table 14. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sale Price by Downstream (2017-2022) & (US$/Box)
Table 15. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Company (2020-2022) & (Box)
Table 16. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sale Price by Company (2020-2022) & (US$/Box)
Table 20. Key Manufacturers Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Producing Area Distribution and Sales Area
Table 21. Players Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Products Offered
Table 22. Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Geographic Region (2017-2022) & (Box)
Table 26. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Country/Region (2017-2022) & (Box)
Table 30. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Country (2017-2022) & (Box)
Table 34. Americas Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Type (2017-2022) & (Box)
Table 38. Americas Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share by Activity (2017-2022)
Table 39. Americas Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Downstream (2017-2022) & (Box)
Table 40. Americas Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share by Downstream (2017-2022)
Table 41. APAC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Region (2017-2022) & (Box)
Table 42. APAC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Activity (2017-2022) & (Box)
Table 46. APAC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share by Activity (2017-2022)
Table 47. APAC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Downstream (2017-2022) & (Box)
Table 48. APAC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share by Downstream (2017-2022)
Table 49. Europe Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Country (2017-2022) & (Box)
Table 50. Europe Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Type (2017-2022) & (Box)
Table 54. Europe Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share by Activity (2017-2022)
Table 55. Europe Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Downstream (2017-2022) & (Box)
Table 56. Europe Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share by Downstream (2017-2022)
Table 57. Middle East & Africa Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Country (2017-2022) & (Box)
Table 58. Middle East & Africa Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Activity (2017-2022) & (Box)
Table 62. Middle East & Africa Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share by Activity (2017-2022)
Table 63. Middle East & Africa Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales by Downstream (2017-2022) & (Box)
Table 64. Middle East & Africa Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share by Downstream (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine
Table 66. Key Market Challenges & Risks of Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine
Table 67. Key Industry Trends of Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine
Table 68. Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Distributors List
Table 71. Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Customer List
Table 72. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Forecast by Region (2023-2028) & (Box)
Table 73. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Forecast by Region
Table 74. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Forecast by Country (2023-2028) & (Box)
Table 77. Americas Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Forecast by Region (2023-2028) & (Box)
Table 79. APAC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Forecast by Country (2023-2028) & (Box)
Table 81. Europe Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Forecast by Country (2023-2028) & (Box)
Table 83. Middle East & Africa Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Forecast by Activity (2023-2028) & (Box)
Table 85. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share Forecast by Activity (2023-2028)
Table 86. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Forecast by Activity (2023-2028) & ($ Millions)
Table 87. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Market Share Forecast by Activity (2023-2028)
Table 88. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Forecast by Downstream (2023-2028) & (Box)
Table 89. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales Market Share Forecast by Downstream (2023-2028)
Table 90. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Forecast by Downstream (2023-2028) & ($ Millions)
Table 91. Global Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Revenue Market Share Forecast by Downstream (2023-2028)
Table 92. CNADC Basic Information, Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. CNADC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
Table 94. CNADC Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 95. CNADC Main Business
Table 96. CNADC Latest Developments
Table 97. Harbin Pharm Basic Information, Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Harbin Pharm Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
Table 99. Harbin Pharm Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 100. Harbin Pharm Main Business
Table 101. Harbin Pharm Latest Developments
Table 102. DBN Basic Information, Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. DBN Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
Table 104. DBN Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 105. DBN Main Business
Table 106. DBN Latest Developments
Table 107. Ringpu Basic Information, Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Ringpu Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
Table 109. Ringpu Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 110. Ringpu Main Business
Table 111. Ringpu Latest Developments
Table 112. Wuhan Zhongbo Biology Basic Information, Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Wuhan Zhongbo Biology Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
Table 114. Wuhan Zhongbo Biology Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 115. Wuhan Zhongbo Biology Main Business
Table 116. Wuhan Zhongbo Biology Latest Developments
Table 117. Nannong Hi-tech Basic Information, Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Nannong Hi-tech Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
Table 119. Nannong Hi-tech Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 120. Nannong Hi-tech Main Business
Table 121. Nannong Hi-tech Latest Developments
Table 122. HPBG Basic Information, Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. HPBG Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
Table 124. HPBG Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 125. HPBG Main Business
Table 126. HPBG Latest Developments
Table 127. Huizhong Biolgoical Basic Information, Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Huizhong Biolgoical Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
Table 129. Huizhong Biolgoical Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 130. Huizhong Biolgoical Main Business
Table 131. Huizhong Biolgoical Latest Developments
Table 132. Qilu Animal Health Basic Information, Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Qilu Animal Health Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
Table 134. Qilu Animal Health Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 135. Qilu Animal Health Main Business
Table 136. Qilu Animal Health Latest Developments
Table 137. Haid Group Basic Information, Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Haid Group Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
Table 139. Haid Group Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 140. Haid Group Main Business
Table 141. Haid Group Latest Developments
Table 142. Zhenye Biologcal Basic Information, Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. Zhenye Biologcal Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Product Offered
Table 144. Zhenye Biologcal Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 145. Zhenye Biologcal Main Business
Table 146. Zhenye Biologcal Latest Developments
Table 147. Tecbond Basic Information, Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 148. Tecbond Transmissible Gastro
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)